SG3376 [CAS 2139261-06-4]

SG3376 is an antibody-drug conjugate (ADC) targeting human epidermal growth factor receptor 2 (HER2) . SG3376 is promising for research of HER2-overexpressing cancers (e.g., breast, gastric cancer) [1].

[2139261-06-4]

C57H63N7O14

1070.15

O=C1C2=CC(OC)=C(OCC3=CC(COC4=C(C=C5C(N=C[C@@]6([H])N(C=C(C6)C)C5=O)=C4)OC)=CC(C#CCNC(CCOCCOCCOCCOCCNC(CCN7C(C=CC7=O)=O)=O)=O)=C3)C=C2N=C[C@@]8([H])N1C=C(C8)C

Drug-Linker Conjugates for ADC; EGFR

Room temperature